Work

Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2639

Authors: Hoyoung M. Maeng, Lauren Virginia Wood, Brittni Moore, Mohammadhadi H. Bagheri, Santhana Webb, Lee England, Giselle Martinez, Seth M. Steinberg, Svetlana Pack, David Stroncek, John Charles Morris, Masaki Terabe, Jay A. Berzofsky

Institutions: National Cancer Institute, Center for Cancer Research, National Institutes of Health, National Institutes of Health Clinical Center, University of Cincinnati

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947938323

Cites:

Cited by: 8

Related to: 10